Literature DB >> 28885825

Nanoparticle Biokinetics in Mice and Nonhuman Primates.

Peter A Chiarelli, Richard A Revia, Zachary R Stephen, Kui Wang, Mike Jeon, Veronica Nelson1, Forrest M Kievit, Jonathan Sham, Richard G Ellenbogen, Hans-Peter Kiem1, Miqin Zhang.   

Abstract

Despite the preponderance of iron oxide nanoparticles (NPs) designed for theranostic applications, widespread clinical translation of these NPs lags behind. A better understanding of how NP pharmacokinetics vary between small and large animal models is needed to rapidly customize NPs for optimal performance in humans. Here we use noninvasive magnetic resonance imaging (MRI) to track iron oxide NPs through a large number of organ systems in vivo to investigate NP biokinetics in both mice and nonhuman primates. We demonstrate that pharmacokinetics are similar between mice and macaques in the blood, liver, spleen, and muscle, but differ in the kidneys, brain, and bone marrow. Our study also demonstrates that full-body MRI is practical, rapid, and cost-effective for tracking NPs noninvasively with high spatiotemporal resolution. Our techniques using a nonhuman primate model may provide a platform for testing a range of NP formulations.

Entities:  

Keywords:  biokinetics; cross-species; iron oxide nanoparticle; magnetic resonance imaging; mice; nonhuman primates

Mesh:

Substances:

Year:  2017        PMID: 28885825      PMCID: PMC6002853          DOI: 10.1021/acsnano.7b05377

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  52 in total

1.  Differential analysis of animal bone marrow by flow cytometry.

Authors:  R A Martin; D A Brott; J C Zandee; M J McKeel
Journal:  Cytometry       Date:  1992

Review 2.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

Review 3.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

4.  ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.

Authors:  Samuel H Crayton; Drew R Elias; Ajlan Al Zaki; Zhiliang Cheng; Andrew Tsourkas
Journal:  Biomaterials       Date:  2011-11-17       Impact factor: 12.479

Review 5.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Authors:  Marcella Martignoni; Geny M M Groothuis; Ruben de Kanter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

Review 6.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

7.  Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings.

Authors:  Anne-Charlotte Faure; Sandrine Dufort; Véronique Josserand; Pascal Perriat; Jean-Luc Coll; Stéphane Roux; Olivier Tillement
Journal:  Small       Date:  2009-11       Impact factor: 13.281

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

Review 9.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

10.  Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat.

Authors:  Åsa Barrefelt; Maryam Saghafian; Raoul Kuiper; Fei Ye; Gabriella Egri; Moritz Klickermann; Torkel B Brismar; Peter Aspelin; Mamoun Muhammed; Lars Dähne; Moustapha Hassan
Journal:  Int J Nanomedicine       Date:  2013-08-26
View more
  7 in total

1.  Theranostic Nanoparticles for RNA-Based Cancer Treatment.

Authors:  Richard A Revia; Zachary R Stephen; Miqin Zhang
Journal:  Acc Chem Res       Date:  2019-05-28       Impact factor: 22.384

2.  Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial.

Authors:  Hamed Arami; Chirag B Patel; Steven J Madsen; Peter J Dickinson; Ryan M Davis; Yitian Zeng; Beverly K Sturges; Kevin D Woolard; Frezghi G Habte; Demir Akin; Robert Sinclair; Sanjiv S Gambhir
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

Review 3.  Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

Authors:  Liron L Israel; Anna Galstyan; Eggehard Holler; Julia Y Ljubimova
Journal:  J Control Release       Date:  2020-01-07       Impact factor: 9.776

4.  Cocaine analogue conjugated magnetic nanoparticles for labeling and imaging dopaminergic neurons.

Authors:  Mike Jeon; Guanyou Lin; Zachary R Stephen; Josey E Vechey; Manjot Singh; Richard Revia; Amy Hauck Newman; Diana Martinez; Miqin Zhang
Journal:  Biomater Sci       Date:  2020-06-09       Impact factor: 6.843

5.  A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis.

Authors:  Guanyou Lin; Qingxin Mu; Richard Revia; Zachary Stephen; Mike Jeon; Miqin Zhang
Journal:  Biomater Sci       Date:  2021-01-26       Impact factor: 6.843

Review 6.  Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives.

Authors:  Mike Jeon; Mackenzie V Halbert; Zachary R Stephen; Miqin Zhang
Journal:  Adv Mater       Date:  2020-06-04       Impact factor: 32.086

7.  Imaging Characteristics of USPIO Nanoparticles (<5 nm) as MR Contrast Agent In Vitro and in the Liver of Rats.

Authors:  Xiaohong Ma; Shuang Wang; Longbin Hu; Shichao Feng; Zhiyuan Wu; Siyun Liu; Shaofeng Duan; Zhongwei Chen; Chunwu Zhou; Xinming Zhao
Journal:  Contrast Media Mol Imaging       Date:  2019-07-21       Impact factor: 3.161

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.